143 related articles for article (PubMed ID: 32149397)
1. Clinicopathological features and oncological outcomes of patients with young-onset rectal cancer.
Zaborowski AM; Murphy B; Creavin B; Rogers AC; Kennelly R; Hanly A; Martin ST; O'Connell PR; Sheahan K; Winter DC
Br J Surg; 2020 Apr; 107(5):606-612. PubMed ID: 32149397
[TBL] [Abstract][Full Text] [Related]
2. Prognostic factors and patterns of failure after surgery for T4 rectal cancer in the beyond total mesorectal excision era.
Peacock O; Waters PS; Bressel M; Lynch AC; Wakeman C; Eglinton T; Koh CE; Lee PJ; Austin KK; Warrier SK; Solomon MJ; Frizelle FA; Heriot AG
Br J Surg; 2019 Nov; 106(12):1685-1696. PubMed ID: 31339561
[TBL] [Abstract][Full Text] [Related]
3. Impact of rectal perforation on recurrence during rectal cancer surgery in a national population registry.
Jörgren F; Lydrup ML; Buchwald P
Br J Surg; 2020 Dec; 107(13):1818-1825. PubMed ID: 32484249
[TBL] [Abstract][Full Text] [Related]
4. Randomized clinical trial of endoluminal locoregional resection versus laparoscopic total mesorectal excision for T2 rectal cancer after neoadjuvant therapy.
Lezoche E; Baldarelli M; Lezoche G; Paganini AM; Gesuita R; Guerrieri M
Br J Surg; 2012 Sep; 99(9):1211-8. PubMed ID: 22864880
[TBL] [Abstract][Full Text] [Related]
5. Prognostic implications of MRI-detected lateral nodal disease and extramural vascular invasion in rectal cancer.
Schaap DP; Ogura A; Nederend J; Maas M; Cnossen JS; Creemers GJ; van Lijnschoten I; Nieuwenhuijzen GAP; Rutten HJT; Kusters M
Br J Surg; 2018 Dec; 105(13):1844-1852. PubMed ID: 30079958
[TBL] [Abstract][Full Text] [Related]
6. Outcomes following surgery without radiotherapy for rectal cancer.
Mathis KL; Larson DW; Dozois EJ; Cima RR; Huebner M; Haddock MG; Wolff BG; Nelson H; Pemberton JH
Br J Surg; 2012 Jan; 99(1):137-43. PubMed ID: 22052336
[TBL] [Abstract][Full Text] [Related]
7. [Value of postoperative adjuvant chemotherapy in locally advanced rectal cancer patients with ypT1-4N0 after neo-adjuvant chemoradiotherapy].
You KY; Peng HH; Gao YH; Chen L; Zhou GQ; Chang H; Du XJ; Xiao L; Zeng ZF; Wen BX; Liu MZ
Zhonghua Zhong Liu Za Zhi; 2013 Sep; 35(9):708-13. PubMed ID: 24332061
[TBL] [Abstract][Full Text] [Related]
8. The effect of adjuvant chemotherapy on survival and recurrence after curative rectal cancer surgery in patients who are histologically node negative after neoadjuvant chemoradiotherapy.
Baird DLH; Denost Q; Simillis C; Pellino G; Rasheed S; Kontovounisios C; Tekkis PP; Rullier E
Colorectal Dis; 2017 Nov; 19(11):980-986. PubMed ID: 28493401
[TBL] [Abstract][Full Text] [Related]
9. Outcomes in locally advanced rectal cancer with highly selective preoperative chemoradiotherapy.
Williamson JS; Jones HG; Davies M; Evans MD; Hatcher O; Beynon J; Harris DA;
Br J Surg; 2014 Sep; 101(10):1290-8. PubMed ID: 24924947
[TBL] [Abstract][Full Text] [Related]
10. Carcinoma microsatellite instability status as a predictor of benefit from fluorouracil-based adjuvant chemotherapy for stage II rectal cancer.
Yang L; Sun Y; Huang XE; Yu DS; Zhou JN; Zhou X; Li DZ; Guan X
Asian Pac J Cancer Prev; 2015; 16(4):1545-51. PubMed ID: 25743829
[TBL] [Abstract][Full Text] [Related]
11. Adjuvant Chemotherapy Does Not Improve Recurrence-Free Survival in Patients With Stage 2 or Stage 3 Rectal Cancer After Neoadjuvant Chemoradiotherapy and Total Mesorectal Excision.
Voss RK; Lin JC; Roper MT; Al-Temimi MH; Ruan JH; Tseng WH; Tam M; Sherman MJ; Klaristenfeld DD; Tomassi MJ
Dis Colon Rectum; 2020 Apr; 63(4):427-440. PubMed ID: 31996583
[TBL] [Abstract][Full Text] [Related]
12. Oncological outcome after MRI-based selection for neoadjuvant chemoradiotherapy in the OCUM Rectal Cancer Trial.
Ruppert R; Junginger T; Ptok H; Strassburg J; Maurer CA; Brosi P; Sauer J; Baral J; Kreis M; Wollschlaeger D; Hermanek P; Merkel S;
Br J Surg; 2018 Oct; 105(11):1519-1529. PubMed ID: 29744860
[TBL] [Abstract][Full Text] [Related]
13. Watch-and-wait approach versus surgical resection after chemoradiotherapy for patients with rectal cancer (the OnCoRe project): a propensity-score matched cohort analysis.
Renehan AG; Malcomson L; Emsley R; Gollins S; Maw A; Myint AS; Rooney PS; Susnerwala S; Blower A; Saunders MP; Wilson MS; Scott N; O'Dwyer ST
Lancet Oncol; 2016 Feb; 17(2):174-183. PubMed ID: 26705854
[TBL] [Abstract][Full Text] [Related]
14. Microsatellite instability in young patients with rectal cancer: molecular findings and treatment response.
REACCT Collaborative
Br J Surg; 2022 Feb; 109(3):251-255. PubMed ID: 35030243
[No Abstract] [Full Text] [Related]
15. Preoperative chemoradiation and coloanal J pouch reconstruction for low rectal cancer.
Chaudhry V; Nittala M; Prasad ML
Am Surg; 2000 Apr; 66(4):387-93. PubMed ID: 10776877
[TBL] [Abstract][Full Text] [Related]
16. Is adjuvant chemotherapy really needed after curative surgery for rectal cancer patients who are node-negative after neoadjuvant chemoradiotherapy?
Kiran RP; Kirat HT; Burgess AN; Nisar PJ; Kalady MF; Lavery IC
Ann Surg Oncol; 2012 Apr; 19(4):1206-12. PubMed ID: 21935748
[TBL] [Abstract][Full Text] [Related]
17. Is neoadjuvant chemoradiation with dose-escalation and consolidation chemotherapy sufficient to increase surgery-free and distant metastases-free survival in baseline cT3 rectal cancer?
São Julião GP; Habr-Gama A; Vailati BB; Aguilar PB; Sabbaga J; Araújo SEA; Mattacheo A; Alexandre FA; Fernandez LM; Gomes DB; Gama-Rodrigues J; Perez RO
Eur J Surg Oncol; 2018 Jan; 44(1):93-99. PubMed ID: 29217398
[TBL] [Abstract][Full Text] [Related]
18. Prognostic subdivision of ypT3 rectal tumours according to extension beyond the muscularis propria.
Merkel S; Weber K; Schellerer V; Göhl J; Fietkau R; Agaimy A; Hohenberger W; Hermanek P
Br J Surg; 2014 Apr; 101(5):566-72. PubMed ID: 24477831
[TBL] [Abstract][Full Text] [Related]
19. The effects of chemoradiotherapy on recurrence and survival in locally advanced rectal cancers with curative total mesorectal excision: a prospective, nonrandomized study.
Akgun E; Ozkok S; Tekin M; Yoldas T; Caliskan C; Kose T; Karabulut B; Sezak M; Elmas N; Ozutemiz O
World J Surg Oncol; 2017 Nov; 15(1):205. PubMed ID: 29166925
[TBL] [Abstract][Full Text] [Related]
20. Fluorouracil-based adjuvant chemotherapy after preoperative chemoradiotherapy in rectal cancer: long-term results of the EORTC 22921 randomised study.
Bosset JF; Calais G; Mineur L; Maingon P; Stojanovic-Rundic S; Bensadoun RJ; Bardet E; Beny A; Ollier JC; Bolla M; Marchal D; Van Laethem JL; Klein V; Giralt J; Clavère P; Glanzmann C; Cellier P; Collette L;
Lancet Oncol; 2014 Feb; 15(2):184-90. PubMed ID: 24440473
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
